Skip to main content
SpringerLink
Log in

Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Laubach JP, Moslehi SAF, San Miguel JF et al (2017) A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for treatment of multiple myeloma: towards providing a benchmark for cardiac safety profile of proteasome inhibition in multiple myeloma. Br J Haem 178(4):547–560. https://doi.org/10.1111/bjh.14708

    Article  CAS  Google Scholar 

  2. Mikhael JR, Schuster SR, Jimenez-Zepeda VH, Bello N, Spong J, Reeder CB et al (2012) Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis. Blood 119(19):4391–4394

    Article  CAS  Google Scholar 

  3. Cole DC, Frishman WH (2018) Cardiovascular complications of proteasome inhibitors used in multiple myeloma. Cardiol Rev 26(3):122–129. https://doi.org/10.1097/CRD.0000000000000183

    Article  PubMed  Google Scholar 

  4. Meseeha MG, Kolade VO, Attia MN (2015) Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy. J Community Hosp Intern Med Perspect 5(6):28982. https://doi.org/10.3402/jchimp.v5.28982

    Article  PubMed  Google Scholar 

  5. Bockorny M, Chakravarty S, Schulman P, Bockorny B, Bona R (2012) Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature. Acta Haematol 128(4):244–247. https://doi.org/10.1159/000340050

    Article  PubMed  Google Scholar 

  6. Kumar SK, Gertz MA, Dispenzieri A (2019) Validation of Mayo Clinic Staging System for light chain amyloidosis with high-sensitivity troponin. J Clin Oncol 37(2):171–173

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. PhD in Experimental Medicine, University of Pavia, Pavia, Italy

    Valentino Dammassa

  2. Adult Intensive Care Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK

    Valentino Dammassa

  3. Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

    Alessandra Greco, Rossana Totaro, Rita Camporotondo & Luigi Oltrona Visconti

  4. Anesthesia and Intensive Care, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

    Costanza Natalia Julia Colombo, Francesco Mojoli & Guido Tavazzi

  5. Division of Cardiology, AOU Città Della Salute e Della Scienza Di Torino, Torino, Italy

    Claudia Raineri & Gaetano Maria De Ferrari

  6. Section of Cardiology, Department of Medical Sciences, University of Turin, Torino, Italy

    Gaetano Maria De Ferrari

  7. Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, Fondazione IRCCS Policlinico San Matteo, Unit of Anesthesia and Intensive Care, University of Pavia, Pavia, Italy

    Francesco Mojoli & Guido Tavazzi

  8. Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

    Eloisa Arbustini

Authors
  1. Valentino Dammassa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandra Greco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rossana Totaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Costanza Natalia Julia Colombo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claudia Raineri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rita Camporotondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gaetano Maria De Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Francesco Mojoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Eloisa Arbustini
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Luigi Oltrona Visconti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Guido Tavazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valentino Dammassa.

Ethics declarations

Ethics approval and consent to participate

This article does not contain any studies involving human participants and/or animals. This article is based on a case report involving a single patient; informed consent was obtained.

Conflict of interest

FM received fees for lectures from GE Healthcare, Hamilton Medical, SEDA SpA, outside the present work. GT received fees for lectures from GE Healthcare, outside the present work.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Valentino Dammassa and Alessandra Greco shared first authorship.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (MP4 19 KB)

Supplementary file2 (MP4 23 KB)

Supplementary file3 (MP4 1145 KB)

Supplementary file4 (MOV 9939 KB)

Supplementary file5 (MP4 1158 KB)

Supplementary file6 (MP4 1112 KB)

Supplementary file7 (MOV 2977 KB)

Supplementary file8 (MOV 1209 KB)

Supplementary file9 (MP4 27 KB)

Supplementary file10 (MP4 37 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dammassa, V., Greco, A., Totaro, R. et al. Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis. Ann Hematol 101, 2087–2088 (2022). https://doi.org/10.1007/s00277-022-04858-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-04858-z

Search

Navigation